Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BIOMARKER FOR DIAGNOSING AND PREDICTING METASTASIS OR PROGNOSIS OF VARIOUS CANCERS, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/270926
Kind Code:
A1
Abstract:
The present invention relates to a novel biomarker for diagnosing cancer, and a use thereof. STC1, a novel biomarker for diagnosing or predicting the prognosis of cancer according to the present invention, was found to be related to poor prognosis of cancer patients according to the expression level, and was found to be overexpressed in various cancer cells. In addition, STC1 was found to be a biomarker related to the proliferation, invasion, and migration (metastasis) of cancer cells. In addition, it was found that STC1 is detected in the serum or urine of bladder cancer patients, and can be effectively used for diagnosing and predicting the prognosis of bladder cancer by identifying differences in expression according to the patient's clinical stage.

Inventors:
LEEM SUN-HEE (KR)
MUN JEONG-YEON (KR)
JEONG MI-SO (KR)
KIM MIN-HYE (KR)
YANG GI-EUN (KR)
Application Number:
PCT/KR2022/008902
Publication Date:
December 29, 2022
Filing Date:
June 22, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV DONG A RES FOUND FOR IND ACAD COOP (KR)
International Classes:
C12Q1/6886
Foreign References:
US20200261490A12020-08-20
Other References:
ZHAO FANGYU, YANG GANG, FENG MENGYU, CAO ZHE, LIU YUEZE, QIU JIANGDONG, YOU LEI, ZHENG LIANFANG, ZHANG TAIPING, ZHAO YUPEI: "Expression, function and clinical application of stanniocalcin‐1 in cancer", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, vol. 24, no. 14, 1 July 2020 (2020-07-01), RO , pages 7686 - 7696, XP093016375, ISSN: 1582-1838, DOI: 10.1111/jcmm.15348
WANG YAN, QI ZIHAO, ZHOU MENGLONG, YANG WANG, HU RAN, LI GUICHAO, MA XUEJUN, ZHANG ZHEN: "Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2", ONCOLOGY REPORTS, vol. 41, no. 3, 1 March 2019 (2019-03-01), pages 1998 - 2008, XP093016380, ISSN: 1021-335X, DOI: 10.3892/or.2019.6980
SU JINGYUAN; GUO BINGYU; ZHANG TINGTING; WANG KANWEN; LI XIAOMING; LIANG GUOBIAO: "Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients", TUMOR BIOLOGY, vol. 36, no. 8, 18 March 2015 (2015-03-18), CH , pages 6333 - 6339, XP036218533, ISSN: 1010-4283, DOI: 10.1007/s13277-015-3319-0
CHANG ANDY C-M; DOHERTY JUDY; HUSCHTSCHA LILY I.; REDVERS RICHARD; RESTALL CHRISTINA; REDDEL ROGER R.; ANDERSON ROBIN L.: "STC1 expression is associated with tumor growth and metastasis in breast cancer", CLINICAL & EXPERIMENTAL METASTASIS, vol. 32, no. 1, 1 January 2015 (2015-01-01), Dordrecht , pages 15 - 27, XP035436362, ISSN: 0262-0898, DOI: 10.1007/s10585-014-9687-9
HOU JING, CHENG JIGAN, DAI ZEHUA, WEI NA, CHEN HUAN, WANG SHU, DAI MIN, LI LEILEI, WANG HUA, NI QING: "Molecular and Clinical Significance of Stanniocalcin-1 Expression in Breast Cancer Through Promotion of Homologous Recombination-Mediated DNA Damage Repair", FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, vol. 9, 15 October 2021 (2021-10-15), pages 1 - 12, XP093016395, DOI: 10.3389/fcell.2021.731086
SUN JIALE, WEI XUEDONG, YOU JIAWEI, YUE WENCHANG, OUYANG JUN, LING ZHIXIN, HOU JIANQUAN: "STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer", INTERNATIONAL JOURNAL OF GENERAL MEDICINE, vol. 14, 11 September 2021 (2021-09-11), pages 5505 - 5516, XP093016398, DOI: 10.2147/IJGM.S329723
Attorney, Agent or Firm:
WIE, Byoung-Gap (KR)
Download PDF: